Douglas J.E. Elder

2.1k total citations
24 papers, 1.7k citations indexed

About

Douglas J.E. Elder is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Douglas J.E. Elder has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Pharmacology and 8 papers in Genetics. Recurrent topics in Douglas J.E. Elder's work include Inflammatory mediators and NSAID effects (11 papers), Estrogen and related hormone effects (8 papers) and Cancer, Lipids, and Metabolism (3 papers). Douglas J.E. Elder is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Estrogen and related hormone effects (8 papers) and Cancer, Lipids, and Metabolism (3 papers). Douglas J.E. Elder collaborates with scholars based in United Kingdom, Canada and United States. Douglas J.E. Elder's co-authors include Christos Paraskeva, Angela Hague, C Paraskeva, Andrew Hague, David J. Kelly, Jeremy M. Tavaré, Emma E. Vincent, Elaine Thomas, Tracey E. Crew and Joya Pawade and has published in prestigious journals such as Nature Medicine, Molecular Cell and Gastroenterology.

In The Last Decade

Douglas J.E. Elder

24 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas J.E. Elder United Kingdom 17 798 580 399 331 299 24 1.7k
Masako Nakanishi United States 22 778 1.0× 481 0.8× 276 0.7× 385 1.2× 458 1.5× 52 1.9k
N Maggiano Italy 21 456 0.6× 333 0.6× 259 0.6× 224 0.7× 198 0.7× 53 1.5k
Chang Han United States 28 1.2k 1.4× 434 0.7× 205 0.5× 519 1.6× 469 1.6× 61 2.5k
Claudia Bocca Italy 25 747 0.9× 187 0.3× 111 0.3× 345 1.0× 197 0.7× 59 1.8k
Altaf Mohammed United States 27 888 1.1× 247 0.4× 131 0.3× 471 1.4× 661 2.2× 96 1.9k
Michihito Takahashi Japan 25 779 1.0× 124 0.2× 215 0.5× 522 1.6× 303 1.0× 125 2.3k
Mayumi Sato Japan 27 1.1k 1.4× 170 0.3× 116 0.3× 133 0.4× 202 0.7× 87 2.1k
Wenxue Sun China 18 470 0.6× 552 1.0× 185 0.5× 138 0.4× 87 0.3× 62 1.4k
W.L. Wendy Hsiao China 29 1.9k 2.3× 246 0.4× 166 0.4× 239 0.7× 444 1.5× 59 2.8k
Cyril Sobolewski Switzerland 20 1.2k 1.5× 233 0.4× 104 0.3× 873 2.6× 133 0.4× 34 2.0k

Countries citing papers authored by Douglas J.E. Elder

Since Specialization
Citations

This map shows the geographic impact of Douglas J.E. Elder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas J.E. Elder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas J.E. Elder more than expected).

Fields of papers citing papers by Douglas J.E. Elder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas J.E. Elder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas J.E. Elder. The network helps show where Douglas J.E. Elder may publish in the future.

Co-authorship network of co-authors of Douglas J.E. Elder

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas J.E. Elder. A scholar is included among the top collaborators of Douglas J.E. Elder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas J.E. Elder. Douglas J.E. Elder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vincent, Emma E., Alexey Sergushichev, Takla Griss, et al.. (2015). Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth. Molecular Cell. 60(2). 195–207. 204 indexed citations
2.
Vincent, Emma E., Douglas J.E. Elder, Linda O′Flaherty, et al.. (2014). Glycogen Synthase Kinase 3 Protein Kinase Activity Is Frequently Elevated in Human Non-Small Cell Lung Carcinoma and Supports Tumour Cell Proliferation. PLoS ONE. 9(12). e114725–e114725. 26 indexed citations
3.
Vincent, Emma E., Douglas J.E. Elder, Jon Curwen, et al.. (2013). Targeting Non-Small Cell Lung Cancer Cells by Dual Inhibition of the Insulin Receptor and the Insulin-Like Growth Factor-1 Receptor. PLoS ONE. 8(6). e66963–e66963. 30 indexed citations
4.
Vincent, Emma E., Douglas J.E. Elder, Elaine Thomas, et al.. (2011). Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer. British Journal of Cancer. 104(11). 1755–1761. 157 indexed citations
5.
Buda, Andrea, Simon Chell, Douglas J.E. Elder, et al.. (2007). Inhibition of COX‐2 with NS‐398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy. Cell Proliferation. 40(5). 768–779. 32 indexed citations
6.
Smartt, Helena J.M., Douglas J.E. Elder, Daniel Hicks, Neil Williams, & Christos Paraskeva. (2003). Increased NF-κB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells. British Journal of Cancer. 89(7). 1358–1365. 18 indexed citations
7.
Eveson, J.W., et al.. (2003). The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.. PubMed. 9(5). 1885–97. 73 indexed citations
8.
Elder, Douglas J.E., et al.. (2002). Human colorectal adenomas demonstrate a size‐dependent increase in epithelial cyclooxygenase‐2 expression. The Journal of Pathology. 198(4). 428–434. 69 indexed citations
9.
Elder, Douglas J.E., et al.. (2002). The MEK/ERK pathway mediates COX‐2‐selective NSAID‐induced apoptosis and induced COX‐2 protein expression in colorectal carcinoma cells. International Journal of Cancer. 99(3). 323–327. 83 indexed citations
10.
11.
12.
13.
Elder, Douglas J.E. & Christos Paraskeva. (1998). COX-2 inhibitors for colorectal cancer. Nature Medicine. 4(4). 392–393. 65 indexed citations
14.
Elder, Douglas J.E., et al.. (1996). Platelet glycoprotein IIIa Pl A polymorphism in young men with myocardial infarction. 5 indexed citations
15.
Hague, Angela, et al.. (1995). Apoptosis in colorectal tumour cells: Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. International Journal of Cancer. 60(3). 400–406. 356 indexed citations
16.
17.
Elder, Douglas J.E. & David J. Kelly. (1994). The bacterial degradation of benzoic acid and benzenoid compounds under anaerobic conditions: Unifying trends and new perspectives. FEMS Microbiology Reviews. 13(4). 441–468. 69 indexed citations
18.
Elder, Douglas J.E., Philip G. Morgan, & David J. Kelly. (1992). Anaerobic degradation of trans-cinnamate and ω-phenylalkane carboxylic acids by the photosynthetic bacterium Rhodopseudomonas palustris: evidence for a β-oxidation mechanism. Archives of Microbiology. 157(2). 148–154. 34 indexed citations
19.
Elder, Douglas J.E., Philip G. Morgan, & David J. Kelly. (1992). Evidence for two differentially regulated phenylpropenoyl-coenzyme A synthetase activities inRhodopseudomanas palustris. FEMS Microbiology Letters. 98(1-3). 255–260. 13 indexed citations
20.
Blajchman, M.A., et al.. (1979). Platelet Transfusion‐Induced Serratia Marcescens Sepsis due to Vacuum Tube Contamination. Transfusion. 19(1). 39–44. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masako Nakanishi Breakdown of academic impact, for papers by N Maggiano Breakdown of academic impact, for papers by Chang Han Breakdown of academic impact, for papers by Claudia Bocca Breakdown of academic impact, for papers by Altaf Mohammed Breakdown of academic impact, for papers by Michihito Takahashi Breakdown of academic impact, for papers by Mayumi Sato Breakdown of academic impact, for papers by Wenxue Sun Breakdown of academic impact, for papers by W.L. Wendy Hsiao Breakdown of academic impact, for papers by Cyril Sobolewski
Rankless by CCL
2026